Member Info for BuenaVista

Avacta have project plans for each of their programmes which they've been keeping close to. Obviously not everything is under their direct control, both unexpected opportunities as well as delays. The important thing is that THEY are ready to go when external actors have done their part, such as approving an IND application. Included in the plans will be contingencies for funding, which will obviously include dilutionary options.

Best not to try to second guess what will happen or when. Either trust the management or take your money out and put it elsewhere, and TocanOfDoom, please stop TRYING to sound like a prat.

PC's could be patient cohorts, although that is not a standard abbreviation.

Do you think they would RNS an IND application submission? I don't think so, in that I'm not expecting an RNS about that but rather, some time in early 2026, an RNS announcing approval of the IND. I'm sure they are working as closely as they can with the FDA, so hopefully the approval will be straightforward - i.e. not sent back for clarification or for further data/information.

...and decent traders

Eh-up, it's eggy's gimp.

You're not invested you sad twat.

Eggy pretending he's got Avacta shares is so funny.🤣🤣🤣

Your idea to do that or TW's?

"I have my honour to uphold after all" on an anonymous BB is code for 'insecure'.

Still collecting TW's 10p's then eggy?

Have you had your Christmas bonus from TW yet eggy?

Hey, don't underestimate his knowledge of the relative merits and failings of the various makes and styles of hospital trolley. Nor his skill in knowing where to find the gamest nurses. Cut him some slack and give him credit. He's worked hard at these.

It'll be the hugest conference ever. Everyone's saying so.

Actually Yule all know it's about midwinter.

Keep digging eggy.😂

I observed that eggy is full of faecal matter, so I changed my mind. What do you do sir?

"And TNBC was more or less chosen at random"

😂😂😂

Don't forget the classic "I guess 6104 will deliver doxorubicin."

Firstly, SGC would be very far down the list of indications for AVA6103 or AVA6207 to treat, if ever.

Secondly, Avacta can offer an exclusive pre|CISION-wide licence for SGC, meaning no other company can use any pre|CISION drug for SGC and/or whichever company licenses faridox for SGC gets first dibs to use new Avacta drugs in the SGC indication.

ToucanOfDoom wrote a complete and utter load of b*ll*cks: "Avacta won’t take 6000 into P2. Probably no one will. They will keep up the pretence until 3Q26 when first 6103 clinical results get published. Why would they 6103 offers a far superior delivery mechanism. I guess 6104 will deliver doxorubicin."

Not a single concept of intelligence in the whole lot of that.

Just a reminder to everyone that eggy is off on some track that the company and clinicians are not fussing about.

Now back to you eggy and whatever you were digging into...

Thus spake the narcissist.

No one cares what you say. You've proved yourself a self-obssessed vanity bucket time and time again.

No integrity. No credibility. Our very own little Mr Trump.

But keep digging eggy.